Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.56USD
20 Oct 2014
Price Change (% chg)

$0.03 (+4.87%)
Prev Close
$0.54
Open
$0.54
Day's High
$0.58
Day's Low
$0.54
Volume
17,454
Avg. Vol
51,470
52-wk High
$2.23
52-wk Low
$0.45

ACST.OQ

Chart for ACST.OQ

About

Acasti Pharma Inc. (Acasti) is engaged in developing a product portfolio of long-chain omega-3 phospholipids. Acasti is a majority owned subsidiary of Neptune Technologies and Bioressources Inc. (Neptune). The Company has one operating segment: the development and commercialization of pharmaceutical applications of its licensed... (more)
No analyst recommendations are available for ACST.OQ.

Overall

No Ratios Available.

Financials

  ACST.OQ Industry Sector
P/E (TTM): -- 32.74 33.38
EPS (TTM): -- -- --
ROI: -- 18.26 17.53
ROE: -- 18.93 18.34
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks